Amsel Medical Corp. reported the first-in-man use of its Amsel Occluder device (AOD) during complicated vascular surgeries to ligate or occlude, or tie up and block chosen vessels during the procedure. Clinical usage occurred at NYU's Langone Medical Center, and was successful in ligating and occluding the vessels with positive reaction and goal performance.

Coorstek Medical reported its minimally invasive surgical (MIS) sacroiliac fusion implant, Integrity-SI fusion system, has been used in the first human patients. The next-generation device was created through a collaboration with the Mayo Clinic, and acts to prepare, compress and stabilize the joint.

Orthopedic implant and instrumentation firm, Exactech Inc., entered a definitive merger agreement with private equity company, TPG Capital, in a transaction that places the value of Exactech at $625 million. The agreement will provide growth capital to execute the company's strategy, and amounts to $42 in cash per share for shareholders.